Ute Hamann

9.2k total citations
34 papers, 975 citations indexed

About

Ute Hamann is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ute Hamann has authored 34 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Genetics. Recurrent topics in Ute Hamann's work include Estrogen and related hormone effects (11 papers), Epigenetics and DNA Methylation (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Ute Hamann is often cited by papers focused on Estrogen and related hormone effects (11 papers), Epigenetics and DNA Methylation (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Ute Hamann collaborates with scholars based in Germany, United States and United Kingdom. Ute Hamann's co-authors include Hiltrud Brauch, Christina Justenhoven, Beate Pesch, Volker Harth, Thomas Brüning, Sylvia Rabstein, Christian Baisch, Christiane Barbara Pierl, Yon‐Dschun Ko and Yon Ko and has published in prestigious journals such as Cancer, Cancer Research and Scientific Reports.

In The Last Decade

Ute Hamann

34 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute Hamann Germany 20 448 287 243 172 159 34 975
Christina Justenhoven Germany 22 503 1.1× 324 1.1× 296 1.2× 184 1.1× 135 0.8× 50 1.1k
Christian Baisch Germany 16 357 0.8× 219 0.8× 232 1.0× 112 0.7× 85 0.5× 25 775
DS Allen United Kingdom 16 228 0.5× 640 2.2× 516 2.1× 195 1.1× 18 0.1× 21 1.3k
Eric D. Wieben United States 26 949 2.1× 262 0.9× 387 1.6× 261 1.5× 138 0.9× 52 1.7k
J. Poortman Netherlands 23 374 0.8× 343 1.2× 900 3.7× 143 0.8× 55 0.3× 54 1.7k
Julie L. Batista United States 17 314 0.7× 233 0.8× 58 0.2× 233 1.4× 5 0.0× 36 1.0k
Jean J. Latimer United States 15 475 1.1× 159 0.6× 116 0.5× 142 0.8× 9 0.1× 39 805
Xiaohong Lei China 14 289 0.6× 169 0.6× 28 0.1× 100 0.6× 124 0.8× 32 744
Christian F. Holinka United States 25 353 0.8× 180 0.6× 1.0k 4.2× 101 0.6× 67 0.4× 65 1.8k
Anh Diep United States 19 438 1.0× 221 0.8× 408 1.7× 170 1.0× 40 0.3× 32 1.0k

Countries citing papers authored by Ute Hamann

Since Specialization
Citations

This map shows the geographic impact of Ute Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Hamann more than expected).

Fields of papers citing papers by Ute Hamann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Hamann. The network helps show where Ute Hamann may publish in the future.

Co-authorship network of co-authors of Ute Hamann

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Hamann. A scholar is included among the top collaborators of Ute Hamann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Hamann. Ute Hamann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manoochehri, Mehdi, Clarissa Gerhäuser, Yassen Assenov, et al.. (2022). DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsy. International Journal of Cancer. 152(5). 1025–1035. 30 indexed citations
2.
Hielscher, Thomas, Clarissa Gerhäuser, Olivia Fletcher, et al.. (2021). Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients. Clinical Epigenetics. 13(1). 207–207. 3 indexed citations
3.
Jones, Michael E., Katarzyna Tomczyk, Olivia Fletcher, et al.. (2020). DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study. Scientific Reports. 10(1). 11762–11762. 10 indexed citations
4.
Rabstein, Sylvia, Volker Harth, Christina Justenhoven, et al.. (2014). Polymorphisms in circadian genes, night work and breast cancer: Results from the GENICA study. Chronobiology International. 31(10). 1115–1122. 38 indexed citations
5.
Lang, Thomas, Christina Justenhoven, Stefan Winter, et al.. (2011). The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans. Breast Cancer Research and Treatment. 129(3). 993–999. 14 indexed citations
6.
Schroth, Werner, Ute Hamann, Peter A. Fasching, et al.. (2010). CYP2D6 Polymorphisms as Predictors of Outcome in Breast Cancer Patients Treated with Tamoxifen: Expanded Polymorphism Coverage Improves Risk Stratification. Clinical Cancer Research. 16(17). 4468–4477. 66 indexed citations
7.
Justenhoven, Christina, Elke Schaeffeler, Stefan Winter, et al.. (2010). Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast Cancer Research and Treatment. 125(2). 563–569. 13 indexed citations
8.
Rabstein, Sylvia, Thomas Brüning, Volker Harth, et al.. (2010). N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer. European Journal of Cancer Prevention. 19(2). 100–109. 22 indexed citations
9.
Dünnebier, Thomas, Klaus Schlaefer, Michael Gilbert, et al.. (2010). No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk. Breast Cancer Research and Treatment. 127(1). 259–264. 1 indexed citations
10.
Justenhoven, Christina, Stefan Winter, Ute Hamann, et al.. (2010). The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors. Cancer. 116(23). 5358–5364. 8 indexed citations
11.
Pesch, Beate, Volker Harth, Sylvia Rabstein, et al.. (2009). Night work and breast cancer – results from the German GENICA study. Scandinavian Journal of Work Environment & Health. 36(2). 134–141. 104 indexed citations
12.
Dünnebier, Thomas, Justo Lorenzo Bermejo, Susanne Haas, et al.. (2009). Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk. Breast Cancer Research and Treatment. 121(1). 185–194. 25 indexed citations
13.
Ji, Yuan, Janet E. Olson, Jianping Zhang, et al.. (2008). Breast Cancer Risk Reduction and Membrane-Bound Catechol O -Methyltransferase Genetic Polymorphisms. Cancer Research. 68(14). 5997–6005. 36 indexed citations
14.
Justenhoven, Christina, Ute Hamann, Christiane Barbara Pierl, et al.. (2008). CYP2C19*17 is associated with decreased breast cancer risk. Breast Cancer Research and Treatment. 115(2). 391–396. 58 indexed citations
15.
Rokavec, Matjaž, Christina Justenhoven, Werner Schroth, et al.. (2007). A Novel Polymorphism in the Promoter Region of ERBB4 Is Associated with Breast and Colorectal Cancer Risk. Clinical Cancer Research. 13(24). 7506–7514. 23 indexed citations
16.
Justenhoven, Christina, Christiane Barbara Pierl, Susanne Haas, et al.. (2007). The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer. Breast Cancer Research and Treatment. 111(1). 171–177. 30 indexed citations
17.
Haas, Susanne, Christiane Barbara Pierl, Volker Harth, et al.. (2006). Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. International Journal of Cancer. 119(8). 1785–1791. 56 indexed citations
18.
Justenhoven, Christina, Ute Hamann, Beate Pesch, et al.. (2005). Breast cancer risk is linked with ERCC2 genotypes and a corresponding haplotype in a German population. Cancer Research. 65. 960–960. 1 indexed citations
19.
Pesch, Beate, Yon Ko, Hiltrud Brauch, et al.. (2005). Factors Modifying the Association Between Hormone-Replacement Therapy and Breast Cancer Risk. European Journal of Epidemiology. 20(8). 699–711. 39 indexed citations
20.
Dupuis, Marc, Manuel C. Peitsch, Ute Hamann, Keith K. Stanley, & Jürg Tschopp. (1993). Mutations in the putative lipid-interaction domain of complement C9 result in defective secretion of the functional protein. Molecular Immunology. 30(1). 95–100. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Justenhoven Breakdown of academic impact, for papers by Christian Baisch Breakdown of academic impact, for papers by DS Allen Breakdown of academic impact, for papers by Eric D. Wieben Breakdown of academic impact, for papers by J. Poortman Breakdown of academic impact, for papers by Julie L. Batista Breakdown of academic impact, for papers by Jean J. Latimer Breakdown of academic impact, for papers by Xiaohong Lei Breakdown of academic impact, for papers by Christian F. Holinka Breakdown of academic impact, for papers by Anh Diep
Rankless by CCL
2026